Sosum M — LTSR HA Filler for Moderate Wrinkles & Lip Enhancement (2 x 1ml)

Sosum M is JSBIO’s medium-density variant — 20 mg/mL cross-linked HA via patented LTSR technology with G’ >250Pa. Lidocaine-free formulation. Engineered for mid-dermal placement targeting nasolabial folds, marionette lines, lip augmentation, and forehead wrinkles. Zero residual BDDE through two-step purification. 2 x 1 mL pack.

Sosum M Moderate Wrinkles Dermal Filler is manufactured by JSBIO Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 2013. The product is part of the Sosum dermal filler range, which is distributed across multiple international markets. Regulatory status: MFDS approval 2013 · CE certified · GMP.

Sosum M Moderate Wrinkles Dermal Filler contains 20 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using JSBIO Co. Ltd.’s Low-Temperature Stabilization Reaction Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per JSBIO Co. Ltd.’s clinical data, Sosum M Moderate Wrinkles Dermal Filler delivers Up to 12 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Mid dermis placement typically delivers the longer end of the duration range.

Sosum M Moderate Wrinkles Dermal Filler is engineered for mid dermis placement. The standard recommended needle is 27G + JBP nanoneedles, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

Sosum M Moderate Wrinkles Dermal Filler regulatory status: MFDS approval 2013 · CE certified · GMP. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store Sosum M Moderate Wrinkles Dermal Filler between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. Sosum M Moderate Wrinkles Dermal Filler uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. Sosum M Moderate Wrinkles Dermal Filler can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

Sosum M is often the default starting point for first-time Sosum patients — its medium density via LTSR technology suits the most common aesthetic concerns (nasolabial folds, moderate wrinkles, lip contouring) without the structural projection of Sosum H or Hard. The 12-month durability allows patients to assess long-term satisfaction before committing to the deeper-grade variants. The lidocaine-free formulation also lets practitioners adjust anaesthesia protocols to first-time patient tolerance.